Back

Real-world efficacy of bempedoic acid: early insights from the BEMPENET Italian Registry

29 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Therapeutic advancements in lipid-lowering pharmacotherapy Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ciro Cotticelli

University of Naples Federico II, Naples (Italy)

3 More presentations in this session

Presentation thumbnail
Understanding discrepancies in trial-level surrogacy of LDL-cholesterol reduction for cardiovascular risk: a methodological appraisal and updated meta-regression
Doctor G. Chen (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
An inclisiran-based treatment strategy reduces the need for therapy escalation to achieve low-density lipoprotein cholesterol goals: Exploratory findings from the VICTORION-Difference trial
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Bempedoic acid for LDL-cholesterol management in patients with and without diabetes: insights from the MILOS study
Professor T. Stulnig (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Therapeutic advancements in lipid-lowering pharmacotherapy

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study
31 August 2026
thumbnail
Congress Presentation
Efficacy of combination therapy with statin and ezetimibe versus high dose statin monotherapy in secondary prevention in high-risk patients
1 September 2024
thumbnail
Congress Presentation
Perceived effectiveness of PCSK9i-SiRNA therapy and adherence to background statin therapy: real-world analysis of the DAMAGE registry
28 August 2026
thumbnail
Congress Presentation
The bempedACS randomized clinical trial
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources